Report: Breast imaging market to hit $5B by 2017
Article Thumbnail ImageJanuary 11, 2013 -- The ever-expanding range of breast-imaging technologies will reach a market value of approximately $5 billion by 2017, according to a market research report by MarketsandMarkets.

To get access to this article and all of the content on, create a free account or sign-in now.

Member Sign In:
  MemberID or E-mail Address:

New Members

Becoming a Member is FREE!

  • Real-time radiology-specific news
  • Case of the Day and Teaching Files
  • Focused topics digital communities
  • Lively, discussion groups
  • Medical imaging bookstore
  • SalaryScan
  • Job Boards
  • Online CME
  • Bookstore, market reports, more …
  • Conference Calendar
  • User-controlled eNewsletters
  • … registration is FREE and easy!
  • The existing and emerging technologies profiled in the report are segmented into radiation-bearing exams and nonionizing tests, the firm said. Ionizing breast imaging modalities include film-screen mammography, full-field digital mammography (FFDM), 3D breast tomosynthesis, conebeam CT (CBCT), positron emission mammography (PEM), molecular breast imaging (MBI), PET, and breast-specific gamma imaging (BSGI). The various nonionizing modalities for breast screening include breast MRI, optical imaging, breast thermography, and breast ultrasound.

    Mammography is the principal modality, followed by MRI, and FFDM is widely accepted for breast cancer screening, the firm said. FFDM comprises more than 45% of the breast imaging market, but the technology's negatives have allowed alternative modalities to attain increasing significance.

    Physicians and healthcare providers are still reluctant to use breast MRI owing mainly to its high investment costs, though new pathways to MRI are being developed in hopes of finding a more cost-effective way to incorporate it into clinical practice.

    CBCT and whole-breast ultrasound are also gaining ground as their quality continues to improve, with a few scanners now available in the market, the firm said. MBI is emerging as a supplemental modality for women with dense breasts. Patient comfort is a main advantage of optical imaging and CBCT because both are performed without breast compression, the report states.

    || About || Advertising || || Bookstore || Breast MRI || Career Center || Case of the Day || Communities || Conferences || Contact Us || ECR News 2014 || Education || Equipment Classifieds || Europe || Facebook || Forums || Home || Links || Marketplace || Middle East || Mobile || Molecular Breast Imaging || New Installations || News in Brief || People in the News || Privacy Policy || RSNA News 2013 || Reference || Salary Survey Results || Trends in Radiology || Twitter || Vendor Connect || Webinars || XML/RSS ||

    Copyright © 2014 All Rights Reserved.